Frontlight ResearchEarly access
Pancreatic cancer trials in Netherlands
49 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peoplePhase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
- Where
- Nijmegen, Utrecht
- Age
- 18 years to 100 years
- People
- 162 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06562192 - Phase 1Taking peopleA Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- Where
- Amsterdam
- Age
- 18 years and over
- People
- 714 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT05208762 · EU 2023-506604-18-00 - Phase 1Taking peopleA Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- Where
- Amsterdam, Groningen
- Age
- 18 years and over
- People
- 914 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT06131840 · EU 2023-505858-18-00 - Phase 2/3Not yet taking people in NetherlandsStudy to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)
- Where
- Nieuwegein
- Age
- 18 years and over
- People
- 175 worldwide
- Run by
- GE Healthcare
See details and how to joinNCT07219238 · EU 2024-519384-18-00 - No phaseNot yet taking people in NetherlandsVenous Resection in Patients Undergoing Pancreatic Surgery
- Where
- Leiden
- Age
- 18 years and over
- People
- 1,000 worldwide
- Run by
- Sahlgrenska University Hospital
See details and how to joinNCT07621029 - Phase 1/2Taking peopleCT-guided Percutaneous Radionuclide Therapy With 32P Microparticles in Patients With Non-progressive Locally Advanced Pancreatic Cancer
- Where
- Amsterdam
- Age
- 18 years and over
- People
- 20
- Run by
- M.R. Meijerink
See details and how to joinNCT07595835 - Phase 1Taking peoplePhase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of [177Lu]Lu-NNS309 in patients with pancreatic, lung, breast and colorectal cancers.
- Where
- Nijmegen, Utrecht
- Age
- 18 years and over
- People
- 76 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2023-510356-23-00 - Phase 2/3Not yet taking people in NetherlandsPREOPANC-6 study: dendritic cell immunotherapy after FOLFIRINOX chemotherapy in patients with resectable pancreatic cancer
- Where
- Amsterdam, Leiden, Maastricht, Rotterdam, Utrecht
- Age
- 18 years and over
- People
- 143
- Run by
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See details and how to join2025-523134-28-00 - No phaseTaking peopleAdditional Treatment for Isolated Local Pancreatic Cancer Recurrence Using Stereotactic Body Radiation Therapy
- Where
- Amsterdam, Rotterdam, Utrecht
- Age
- 18 years and over
- People
- 174
- Run by
- UMC Utrecht
See details and how to joinNCT04881487 - No phaseEnrolling by invitationThe Role of the Human Microbiome in Patients After Pancreatic Resection.
- Where
- Nieuwegein
- Age
- 18 years and over
- People
- 200
- Run by
- St. Antonius Hospital
See details and how to joinNCT06381882 - Phase 3Taking peopleIntensified treatment in patients with oligometastatic pancreatic cancer - multimodal surgical treatment versus systemic chemotherapy alone: a randomized controlled trial - METAPANC
- Where
- Amsterdam, Leiden, Maastricht, Nieuwegein, Rotterdam
- Age
- 18 years and over
- People
- 500 worldwide
- Run by
- Universitaetsmedizin Goettingen
See details and how to join2023-503558-10-00 - No phaseTaking peopleThe MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Where
- Amsterdam, Deventer, Leeuwarden, Nijmegen, Utrecht
- Age
- 18 years and over
- People
- 8,000 worldwide
- Run by
- UMC Utrecht
See details and how to joinNCT04075305 - Phase 1/2Taking peopleNeoadjuvant Triple Therapy for (Borderline) Resectable Pancreatic Cancer (PREOPANC-5)
- Where
- Amsterdam, Maastricht, Nieuwegein, Rotterdam, Utrecht
- Age
- 18 years and over
- People
- 66
- Run by
- Amsterdam UMC, location VUmc
See details and how to joinNCT06384560 · EU 2023-508707-20-00 - Early phase 1CompletedPET-imaging of Two Vartumabs in Patients With Solid Tumors
- Where
- Groningen
- Age
- 18 years and over
- People
- 32
- Run by
- Var2 Pharmaceuticals
See details and how to joinNCT06645808 · EU 2024-513827-18-00 - Phase 4Taking peoplePreventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA)
- Where
- Amsterdam
- Age
- 18 years and over
- People
- 400
- Run by
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
See details and how to joinNCT07262957 - Phase 1/2Taking peoplePhase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI
- Where
- Maastricht, Rotterdam
- Age
- 18 years and over
- People
- 126 worldwide
- Run by
- Maastricht University Medical Center
See details and how to joinNCT04954599 - No phaseTaking peopleLaparoscopic Versus Robot-assisted Left-sided Pancreatectomy for Benign and Pre-malignant Lesions (DIPLOMA-3)
- Where
- Amsterdam
- Age
- 18 years and over
- People
- 256
- Run by
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
See details and how to joinNCT06939023 - No phaseTaking peoplePrediction of Surgical Resectability After FOLFIRINOX Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: the Role of Diffusion Weighted Magnetic Resonance Imaging, Radiomics and Liquid Biopsy (PeRFormanCe Trial)
- Where
- Terneuzen
- Age
- 18 years and over
- People
- 45 worldwide
- Run by
- University Hospital, Ghent
See details and how to joinNCT05298722 - Phase 2/3Taking people68-Ga-FAPI-46 positron emission tomography (PET) to better visualise pancreatic and bile duct cancer.
- Where
- Amsterdam
- Age
- 18 years and over
- People
- 63
- Run by
- Stichting Amsterdam UMC
See details and how to joinNCT05957250 · EU 2024-516486-36-00 - Phase 2Taking peoplePersonalized dosing of FOLFIRINOX in pancreatic cancer patients: a phase-2 pharmacokinetic, safety and feasibility trial
- Where
- Amsterdam, Eindhoven, Leiden, Rotterdam, Zwolle
- Age
- 18 years and over
- People
- 100
- Run by
- Catharina Ziekenhuis Stichting
See details and how to join2024-510576-21-00 - Phase 2Taking peopleNIR-Fluorescence Guided Surgical Resection of Neoadjuvant Treated Localized Pancreatic Cancer Using SGM-101
- Where
- Leiden
- Age
- 18 years and over
- People
- 20
- Run by
- Leiden University Medical Center
See details and how to joinNCT05984810 - No phaseNot yet taking people in NetherlandsLocally Advanced Pancreatic Cancer After Systemic Therapy: Ablative MR-guided Radiotherapy
- Where
- Amsterdam, Eindhoven, Nijmegen, Utrecht
- Age
- 18 years and over
- People
- 150
- Run by
- UMC Utrecht
See details and how to joinNCT06272162 - No phaseTaking peopleImproving Pancreatic Cancer Care by the Use of Computational Science and Technology
- Where
- Utrecht
- People
- 5,000
- Run by
- UMC Utrecht
See details and how to joinNCT06055010 - No phaseTaking peoplePREOPANC-4 Implementation Program for Locally Advanced Pancreatic Cancer
- Where
- Amsterdam
- Age
- 18 years and over
- People
- 223
- Run by
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
See details and how to joinNCT05524090